Definition/General
Introduction:
Radiation-induced changes in urine cytology represent iatrogenic cellular alterations following radiotherapy
These changes result from DNA damage and cellular injury
Acute and chronic phases show different morphological features
Recognition prevents misinterpretation as malignancy.
Origin:
Changes originate from ionizing radiation damage to urothelial cells
DNA strand breaks and chromosomal abnormalities occur
Cellular repair mechanisms become overwhelmed
Vascular damage contributes to tissue injury
Chronic inflammation and fibrosis develop.
Classification:
Classified by temporal relationship to radiation
Acute changes (within days to weeks)
Subacute changes (weeks to months)
Chronic changes (months to years)
Early delayed effects
Late delayed effects.
Epidemiology:
Occurs in 20-40% of patients receiving pelvic radiation
More common with higher radiation doses (>50 Gy)
Concurrent chemotherapy increases risk
Previous pelvic surgery increases susceptibility
Age and comorbidities influence severity
Diabetes increases risk.
Clinical Features
Presentation:
Acute cystitis symptoms (dysuria, frequency)
Hematuria (microscopic or gross)
Urgency and nocturia
Suprapubic pain
Reduced bladder capacity
Chronic pain syndrome possible
Secondary infections common.
Symptoms:
Urinary frequency and urgency
Dysuria (painful urination)
Hematuria (blood in urine)
Pelvic pain
Nocturia (nighttime urination)
Urinary incontinence
Tenesmus (incomplete emptying sensation).
Risk Factors:
High radiation dose (>50 Gy)
Large treatment volume
Concurrent chemotherapy
Previous pelvic surgery
Diabetes mellitus
Advanced age
Smoking
Poor nutritional status
Genetic susceptibility.
Screening:
Regular urinalysis during treatment
Cytological monitoring
Symptom assessment scales
Cystoscopy for severe cases
Imaging studies when indicated
Functional assessments.
Master Radiation Cystitis Changes Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
Hematuria ranging from pink to dark red
Cloudy urine with increased cellularity
Proteinuria may be present
Debris and inflammatory material
Normal color possible in mild cases
Foamy appearance due to protein.
Characteristics:
Increased specific gravity
Protein and blood positive
Cellular debris abundant
Inflammatory exudate
Variable pH levels
Bacterial contamination possible.
Microscopic Description
Immunohistochemistry
Positive Markers:
p53 (accumulation due to DNA damage)
γH2AX (DNA damage marker)
Ki-67 (variable proliferation)
CK7 and CK20 (urothelial origin)
Uroplakin
PCNA (proliferation marker).
Negative Markers:
p16 (usually negative)
High-risk HPV markers
CEA (typically negative)
TTF-1 (negative)
PSA (negative)
Chromogranin (negative).
Diagnostic Utility:
p53 accumulation indicates DNA damage
γH2AX confirms radiation exposure
Ki-67 shows variable patterns
Helps distinguish from malignancy
CK7/CK20 confirm urothelial origin
Clinical correlation essential.
Molecular/Genetic
Differential Diagnosis
Similar Entities:
High-grade urothelial carcinoma
Viral cytopathic effects
Chemotherapy-induced changes
Reactive atypia
Inflammatory changes
Instrumentation trauma.
Distinguishing Features:
Radiation changes: History of radiation, bizarre giant cells
Carcinoma: Monotonous population, irregular chromatin
Viral: Specific inclusions, immunostains positive
Chemotherapy: Drug history, different morphology
Reactive: Inflammatory background.
Diagnostic Challenges:
Severe atypia may mimic malignancy
Bizarre cells very concerning morphologically
Mixed changes complicate interpretation
Temporal relationship to radiation important
Secondary malignancy possible.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
Urine specimen, [collection method], [volume] ml
Clinical History
History of pelvic radiation therapy [dose and timeline]
Specimen Adequacy
Adequate for cytological evaluation
Radiation Changes
Urothelial cells showing radiation-induced changes with [specific features]
Cellular Features
[describe specific morphological changes]
Background
[degree] inflammatory background with [components]
Diagnosis
Radiation-induced changes, [acute/chronic phase]
Differential Diagnosis
No evidence of malignancy. Consider [relevant differentials]
Recommendations
Clinical correlation. Follow-up cytology. Consider cystoscopy if indicated.